Alcidion announces that it has signed an agreement to acquire the business and assets of Kyra Patient Flow Manager, Kyra Queue Manager and Kyra IQ (collectively, the ‘Kyra flow products’) from Telstra Health.
This acquisition further strengthens Alcidion’s position as a leading provider of enterprise patient flow solutions across Australia, New Zealand and the UK.
Highlights:
Alcidion is a market leader in patient flow in ANZ and the UK, with its Miya Precision platform enabling healthcare providers to digitise bed allocation, optimise progression of care, and use clinical decision support to enhance the delivery of patient care and eliminate administrative burden for care workers.
The acquisition of Telstra Health’s Kyra flow products expands Alcidion’s footprint to more than 30 additional healthcare providers across Australia building upon Alcidion’s patient flow presence at Hume, Peninsula Health, Western Health and Alfred, among others.
The Kyra flow products business have customers in five of six Australia states with a significant presence across the Queensland market, a strategically important market noting Alcidion’s recent 5-year contract with Gold Coast Health and several customers in Victoria.
Alcidion CEO and Managing Director, Kate Quirke said:
“This acquisition is highly complementary to our core business and further consolidates our market position in the Australian patient flow market. We see strong strategic and financial alignment as we continue to build a scaled, recurring revenue‑driven health technology company.”
“We look forward to building on Telstra Health’s long-standing customer relationships and believe Alcidion, as an international leader in patient flow, is one of the few industry players with the infrastructure, credibility and expertise to continue delivering the level of support that enterprise government and private health service customers expect.”
“Patient flow continues to be a critical pain point across the healthcare setting with an aging population and increasing rates of hospital admission expected to only further compound the need for validated enterprise digital solutions that both simplify decision support and also remove administrative burden.”
“Alcidion looks forward to welcoming the Kyra customers to our community and to providing continued, excellent service alongside an opportunity to share what Alcidion can offer them as they look to evolve the value they receive from their digital investments for patients and staff.”
“We also look forward to maintaining a relationship with Telstra Health, to leverage the complimentary nature of our respective product suites.”
Telstra Health Managing Director, Elizabeth Koff AM added:
“Telstra Health is building a care intelligence ecosystem, one that connects care, patients and clinicians across the care continuum.
To support that, we’re making clear choices about where we focus, where we invest, and where we partner.
Telstra Health’s Kyra Flow products are a strong set of hospital patient flow and operational solutions, however they do not align with our future roadmap for connecting care. Choosing the right owner for this product suite to continue to support hospital care was critical and required careful consideration. Alcidion fulfilled the criteria comprehensively.
Alcidion brings strong capability, deep industry expertise and a proven track record supporting hospitals. We are confident they are well placed to continue to evolve these products for customers.
For Telstra Health, our new care intelligence ecosystem will serve, connect and enable clinicians and care providers from primary, community and aged care, to hospitals and government services – across every health journey.
Our priority is to ensure a smooth transition for the Kyra Flow products to Alcidion, with continuity of service and support for customers and their teams.”
About Kyra Flow Products
The Kyra flow products include three complementary inpatient and outpatient hospital focused patient flow solutions: